Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
01/2008
01/29/2008US7323446 Growth factor homolog ZVEGF4
01/29/2008US7323445 Methods and compositions for healing and repair of articular cartilage
01/29/2008US7323444 Use of kahalalide compounds for the manufacture of a medicament for the treatment of psoriasis
01/29/2008US7323441 Oral administration in a daily dosage of 150 to 750 mg per day in a form of tablets, capsules, granules, powder, or syrups
01/29/2008US7323440 De-immunized MOG (poly)peptide constructs
01/29/2008US7323340 Compositions and methods for regulating bacterial pathogenesis
01/29/2008US7323339 Breeding plant varieties with an enhanced tolerance to abiotic stresses and for improving plant tolerance to abiotic stresses.
01/29/2008US7323330 Genome sequences and nucleotide sequences coding for the PWD circovirus polypeptides, such as the circovirus structural and non-structural polypeptides, vectors including the sequences, and cells transformed by the vectors; kits for diagnosing infection and vaccines
01/29/2008US7323314 Members of the capsaicin/vanilloid receptor family of proteins and uses thereof
01/29/2008US7323302 Molecular markers
01/29/2008US7323301 Medical diagnosis using chromosomes, nucleic acids
01/29/2008US7323181 Compositions and methods for WT1 specific immunotherapy
01/29/2008US7323180 Use of cross-protection to identify novel vaccine candidates for infectious agents
01/29/2008US7323179 Methods and compositions for the treatment and prevention of Staphylococcus and other bacterial infections
01/29/2008US7323177 delivery vectors for antigen producing genes (heterologous gene sequences or fragments thereof) used to generate immune responses in commercial pigs; recombinant porcine adenovirus capable of expressing DNA of interest
01/29/2008US7323175 Immunogenicity of glucan binding protein
01/29/2008US7323174 Modulation of immune response and methods based thereon
01/29/2008US7323173 Administration of phosphorylated Mammastatin having a molecular weight of 53 kDa or 49 kDa; the polypeptide is specifically reactive with monoclonal antibody 7G6 that is produced from hybridoma ATCC No. HB10152
01/29/2008US7323171 less immunosuppression than pre-existing therapies; anti-LFA-3 antibody homologs, anti-CD2 antibody homologs, soluble LFA-3 polypeptides, small molecules, e.g., carbohydrates, soluble CD2 polypeptides, CD2 or LFA-3 mimetic agents and derivatives
01/29/2008US7323170 Anti-CD80 antibodies
01/29/2008US7323165 Production of pancreatic islet cells and delivery of insulin
01/29/2008US7323164 Can be administered in conjunction with radiation or chemotherapeutic agents.
01/29/2008US7323065 UV irradiation for surface cleaning
01/29/2008CA2417455C Novel cyclooxygenase variants and methods of use
01/29/2008CA2325819C Seed-coat promoters, genes and gene products
01/29/2008CA2267651C Method of stimulating growth of melanocyte precursor cells with stem cell factor polypeptide
01/29/2008CA2207078C Insulin derivatives with increased zinc binding
01/29/2008CA2090650C Method of producing tissue factor pathway inhibitor
01/28/2008CA2595306A1 Recombinant antibodies to sclerotinia antigens
01/24/2008WO2008011624A2 Crystal structure of a receptor-ligand complex and methods of use
01/24/2008WO2008011609A2 Compositions and methods for vaccinating against hsv-2
01/24/2008WO2008010930A2 Hiv-1 peptides, nucleic acids, and compositions, and uses thereof
01/24/2008WO2008010864A2 Modified adenovirus hexon protein and uses thereof
01/24/2008WO2008010840A2 Fsh mutants
01/24/2008WO2008010478A1 Flagellin mutant vaccine
01/24/2008WO2008010218A1 Peptides derived from human histone h2a and methods of use thereof
01/24/2008WO2008010093A2 Meganuclease variants cleaving a dna target sequence from a rag gene and uses thereof
01/24/2008WO2008009977A2 Methods and compositions for modulating socs3
01/24/2008WO2008009953A1 Materials and methods relating to the interaction of p53 and mdm2
01/24/2008WO2008009777A1 Hsv glycoproteins which induce chemokine-mediated cell migration
01/24/2008WO2008009727A1 Positive cytomodulines to improve bioreactor productivity.
01/24/2008WO2008009673A2 Mannanases
01/24/2008WO2008009650A2 Vaccines for malaria
01/24/2008WO2008009600A1 Process for producing arachidonic acid and/or eicosapentaenoic acid in plants
01/24/2008WO2008009565A2 Method for screening an enhancer or a masker of salty taste
01/24/2008WO2008009470A1 Chiral compounds substituted with phosphonate ester or phosphonic acid
01/24/2008WO2008009437A2 Sdf-i binding nucleic acids
01/24/2008WO2008009419A1 Human growth and differentiation factor gdf-5
01/24/2008WO2008009214A1 Polypeptide, nucleic acid molecule encoding it and their uses
01/24/2008WO2007144492A3 Peptides with anti-proliferative activity
01/24/2008WO2007138361A3 Chymotripsin from lucilia sericata larvae and its use for the treatment of wounds
01/24/2008WO2007137984A3 Modified humanised anti-interleukin-18 antibodies
01/24/2008WO2007133596A3 Method and system for production of zein and/or xanthophylls using chromatography
01/24/2008WO2007129072A3 Method and product
01/24/2008WO2007128553A3 Mig12
01/24/2008WO2007115837A3 Combination of an anti-edb fibronectin domain antibody/ il2 fusion protein and a further small molecule
01/24/2008WO2007109733A3 Diagnostic and prognostic markers and treatment strategies for multiple sclerosis
01/24/2008WO2007092537A3 Synthetic hyperglycosylated, and hyperglycosylated protease-resistant polypeptide variants, oral formulations and methods of using the same
01/24/2008WO2007081943A3 Methods and compositions for promoting attachment of cells of endothelial cell lineage to medical devices
01/24/2008WO2007072064A3 Defatting collagen
01/24/2008WO2007072063A3 A bioassay and peptides for use therein
01/24/2008WO2007060548A3 Chimeric, hybrid and tandem polypeptides of meningococcal nmb1870
01/24/2008WO2006101841A3 Seneca valley virus based compositions and methods for treating disease
01/24/2008WO2006099019A8 Methods and composition related to in vivo imaging of gene expression
01/24/2008WO2005091944A3 Glycol linked fgf-21 compounds
01/24/2008WO2005000095A3 Isoforms of brain natriuretic peptide
01/24/2008WO2004081188A3 Non-toxic membrane-translocating peptides
01/24/2008WO2004069206A3 Immunogenic cd91 ligand-antigenic molecule complexes and fusion proteins
01/24/2008WO2003093437A3 Production of papillomavirus vaccines in plants
01/24/2008WO2003070900A3 Cftr with a partially deleted r domain and uses thereof
01/24/2008US20080022427 Transcription Factor Stress-Related Polypeptides and Methods of Use in Plants
01/24/2008US20080021553 Synthesis of spider dragline and/or flagelliform proteins
01/24/2008US20080021211 Rapamycin analogues; diabetes, acute or chronic rejection of an organ or tissue transplant, asthma, tumours, psoriasis, eczema, rheumatoid arthritis, fibrosis, and allergies
01/24/2008US20080021207 Recoded bovine immunodeficiency virus sequence comprising preferred human codons; use in gene delivery
01/24/2008US20080021202 For use in diagnosis and therapy of disease; screening for antagonists and agonists of Apop proteins
01/24/2008US20080021201 Protease inhibitor conjugates and antibodies useful in immunoassay
01/24/2008US20080021082 Small molecule inhibition of a PDZ-domain interaction
01/24/2008US20080020993 Regulation of cell proliferation and differentiation using topically applied nucleic acid molecules
01/24/2008US20080020984 Crystal Structure of a Receptor-Ligand Complex and Methods of Use
01/24/2008US20080020983 Peptides with antioxidant and antimicrobial properties
01/24/2008US20080020979 Peptides of Syndecan-1 For Inhibiting Angiogenesis
01/24/2008US20080020977 Use of Fullerenes to Oxidize Reduced Redox Proteins
01/24/2008US20080020976 Fragment of the C-terminal of dermcidin protein; protective skin treatment
01/24/2008US20080020975 Galanin Receptors and Brain Injury
01/24/2008US20080020970 For promoting the release of growth hormone and of enhancing wound healing in a human or animal subject; for treating short stature, cachexia, wasting, type 2 diabetes, and poor circulation
01/24/2008US20080020969 36 Human Secreted Proteins
01/24/2008US20080020965 Oxidative damage and protease activity resistance; catalytic efficiency; deep vein thrombosis, disseminated intravascular coagulation, acute coronary syndrome; targeting protein, that interacts with tissue factor or the factor VIIa/tissue factor complex
01/24/2008US20080020442 Nucleic acid and amino acid sequences relating to streptococcus pneumoniae for diagnostics and therapeutics
01/24/2008US20080020440 Method of sequestering and/or purifying a polypeptide
01/24/2008US20080020427 using branching enzyme from a bacterium of the genus Neisseria; for use in pharmaceutical/cosmetic industries
01/24/2008US20080020424 Heteromeric umami t1r1/t1r3 taste receptors and isolated cells that express same
01/24/2008US20080020419 The use of saccharomyces cerevisiae erg4 mutants for expressing mammalian glucose transporter
01/24/2008US20080020418 Cftr polypeptides, fragments thereof and methods of use to overcome biosynthetic misprocessing
01/24/2008US20080020415 Diacylglycerol acyltransferases for alteration of polyunsaturated fatty acids and oil content in oleaginous organisms
01/24/2008US20080020412 Aurora expression constructs
01/24/2008US20080020410 Assays for detection of bacillus anthracis
01/24/2008US20080020406 Antibodies to a human Kchannel and therapeutic applications thereof
01/24/2008US20080020404 Search for cancer markers by a novel screening method
01/24/2008US20080020403 Nucleic acid encoding a novel prostaglandin receptor protein and methods of use thereof
01/24/2008US20080020399 Use of IRS-polypeptides for identifying of pharmaceutically active compounds